Zobrazeno 1 - 10
of 478
pro vyhledávání: '"Takeshi yuasa"'
Autor:
Ichiro Yonese, Noboru Numao, Kentaro Inamura, Yusuke Yoneoka, Ryo Fujiwara, Yosuke Yasuda, Tomohiko Oguchi, Shinya Yamamoto, Takeshi Yuasa, Junji Yonese
Publikováno v:
IJU Case Reports, Vol 7, Iss 1, Pp 64-67 (2024)
Introduction Recently, perioperative use of immune checkpoint inhibitors has improved the prognosis of muscle‐invasive bladder cancer. It is unclear whether radical cystectomy or systemic pembrolizumab is the optimal next treatment in patients with
Externí odkaz:
https://doaj.org/article/17d7775a14ee47d8ab8bc364c0c96964
Autor:
Minami Une, Ryo Fujiwara, Arisa Ueki, Ryosuke Oki, Tetsuya Urasaki, Kentaro Inamura, Shunji Takahashi, Junji Yonese, Takeshi Yuasa
Publikováno v:
IJU Case Reports, Vol 6, Iss 5, Pp 286-289 (2023)
Introduction Li–Fraumeni syndrome, an autosomal dominant cancer predisposition syndrome caused by a pathogenic variant of TP53, a tumor suppressor gene, leads to a high risk from early childhood of developing various types of cancers. Here, we repo
Externí odkaz:
https://doaj.org/article/19f307c5fcb141499aca3bf099a9e54d
Autor:
Aya Nishizawa, Koichi Takeda, Tetsuya Urasaki, Makiko Ono, Toshiaki Mochizuki, Taro Shiga, Motohiro Fujiwara, Takeshi Yuasa, Atsushi Murakami, Ryo Koike, Mayu Yunokawa, Hiroyuki Kanao, Keitaro Shimozaki, Daisuke Takahari, Takahiro Kogawa, Shunji Takahashi, Shigehisa Kitano
Publikováno v:
JEADV Clinical Practice, Vol 2, Iss 2, Pp 330-337 (2023)
Abstract Immune checkpoint inhibitor (ICI) therapy is often associated with cutaneous immune‐related adverse events (irAEs). Drug eruptions stemming from concomitantly or consecutively administered medications are also frequent and tend to be sever
Externí odkaz:
https://doaj.org/article/1920eec3d1b2419e9855ae1e1e02aa61
Autor:
Izuma Nakayama, Eiji Shinozaki, Hiroshi Kawachi, Takashi Sasaki, Mayu Yunokawa, Junichi Tomomatsu, Takeshi Yuasa, Satoru Kitazono, Kokoro Kobayashi, Keiko Hayakawa, Arisa Ueki, Shunji Takahashi, Kensei Yamaguchi
Publikováno v:
Cancer Medicine, Vol 12, Iss 7, Pp 7932-7940 (2023)
Abstract Background In Japan, microsatellite instability (MSI) testing for solid tumors was introduced in clinical practice in December 2018. Although immune checkpoint inhibitors (ICIs) are established standards of care for patients with MSI‐high
Externí odkaz:
https://doaj.org/article/9b96c2e100c24760ba571998e28d756d
Autor:
Soichiro Yoshida, Taro Takahara, Yuki Arita, Masaya Ito, Sara Hayakawa, Tomohiko Oguchi, Yoshinobu Komai, Noboru Numao, Takeshi Yuasa, Masaharu Inoue, Hiroki Ushijima, Shigehiro Kudo, Yasumasa Shimano, Yuki Nakamura, Yusuke Uchida, Sho Uehara, Hajime Tanaka, Hiroshi Yaegashi, Kouji Izumi, Minato Yokoyama, Yoh Matsuoka, Yasuo Yoshioka, Koji Konishi, Katsuyuki Nakanishi, Akira Nagahara, Akihiro Hirakawa, Ryuji Koike, Fumitaka Koga, Kazuo Nishimura, Atsushi Mizokami, Junji Yonese, Yukio Kageyama, Ryoichi Yoshimura, Yasuhisa Fujii
Publikováno v:
BMC Urology, Vol 23, Iss 1, Pp 1-9 (2023)
Abstract Background The significance of metastasis-directed therapy for oligometastatic prostate cancer has been widely discussed, and targeted therapy for progressive sites is a feasible option as a multidisciplinary treatment for castration-resista
Externí odkaz:
https://doaj.org/article/a2f96538335345bc92c71087caf16814
Autor:
Takeshi Aoyama, Kenji Nakano, Takeshi Yuasa, Erika Sugiyama, Takako Okawa, Kazuyuki Ito, Keiichi Azuma, Koki Hashimoto, Ryota Furutani, Makoto Hiraide, Kazuo Kobayashi, Kenichi Suzuki, Jyunnichi Tomomatsu, Masataka Tajima, Hitoshi Sato, Toshihiro Hama, Shunji Takahashi
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-9 (2023)
Abstract The safety and effectiveness of pazopanib are related to plasma trough concentrations in renal cell carcinoma (RCC); however, data on pazopanib plasma trough concentrations with soft tissue sarcoma (STS) are limited. This study investigated
Externí odkaz:
https://doaj.org/article/980b2c0f97b242018c4d72bbb6d25e96
Autor:
Ryosuke Oki, Tetsuya Urasaki, Arisa Ueki, Kentaro Inamura, Yoshinobu Komai, Shunji Takahashi, Junji Yonese, Takeshi Yuasa
Publikováno v:
IJU Case Reports, Vol 6, Iss 1, Pp 33-36 (2023)
Introduction In Lynch syndrome, urothelial cancer is the third most common cancer, following colorectal and endometrial cancers. Little is known, however, about the efficacy of immune checkpoint inhibitors in the treatment of metastatic urothelial ca
Externí odkaz:
https://doaj.org/article/a12c51cf117b491abd558a48ae8eff90
Autor:
Eri Fukagawa, Takeshi Yuasa, Kentaro Inamura, Kosuke Hamada, Motohiro Fujiwara, Yoshinobu Komai, Junji Yonese
Publikováno v:
IJU Case Reports, Vol 5, Iss 6, Pp 505-510 (2022)
Introduction Prostatic large‐cell neuroendocrine carcinoma is poorly studied. Although several case reports are available, information on the clinicopathological characteristics of this disease is limited, particularly for the de novo (hormone‐na
Externí odkaz:
https://doaj.org/article/aa4745e457054269b9ad8e5e1fe69359
Autor:
Kasumi Kaneko Yoshitomi, Noboru Numao, Yosuke Umino, Motohiro Fujiwara, Ryo Fujiwara, Tomohiko Oguchi, Yoshinobu Komai, Takeshi Yuasa, Shinya Yamamoto, Junji Yonese
Publikováno v:
IJU Case Reports, Vol 4, Iss 5, Pp 285-288 (2021)
Introduction Although the utility of diffusion‐weighted whole‐body imaging with background body signal suppression for assessing lymph node involvement or distant metastasis is renowned in many cancers, only few studies have revealed its utility
Externí odkaz:
https://doaj.org/article/e470d33066844447aba7740bfae756ce
Autor:
Takeshi Yuasa
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Externí odkaz:
https://doaj.org/article/218b24b7718b47f4baa43c7771a346ef